Inmaculada Bando - Concepedia

Author

Inmaculada Bando

Hospital Clínico San Carlos

Also Known As

Antonio Arrivi, I Bando, I. Bando, Inmaculada Bando

Publications

415

Citations

H-Index

Concepts

All Affiliations

Hospital Clínico San Carlos Instituto de Investigación Sanitaria del Hospital Clínico San Carlos Universidad Complutense de Madrid Centro de Investigación Biomédica en Red de Cáncer Instituto de Salud Carlos III

About

Inmaculada Bando is an author at Hospital Clínico San Carlos specializing in medicine, colorectal cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	168
2	Pathology	6	6	168
3	Public Health	1	1	30
4	Biostatistics	1	1	30
5	Cancer Epidemiology	1	1	30

Inmaculada Bando

Publications

367

Citations

H-Index

Page 1

	Year	Citations
Relationship between expression of HSP70 and metallothionein and oxidative stress during mercury chloride induced acute liver injury in rats Isabel Sánchez Reus, Inmaculada Bando, Marı́a Cascales Journal of Biochemical and Molecular Toxicology	2003	76
Endogenous antioxidant defence system in rat liver following mercury chloride oral intoxication Inmaculada Bando, María Isabel Sánchez Reus, Marı́a Cascales Journal of Biochemical and Molecular Toxicology	2005	68
<i>BRIP1</i> , a Gene Potentially Implicated in Familial Colorectal Cancer Type X Lorena Martín-Morales, Pilar Garré, Víctor Lorca, Cancer Prevention Research	2020	55
<i><scp>BRCA2</scp></i> gene: a candidate for clinical testing in familial colorectal cancer type X Pilar Garré, Atocha Romero, Alicia Tosar, Clinical Genetics Somatic VariantCancer PathologyClinical TestingGeneticsMedicine	2014	37
Influence of KRAS p.G13D Mutation in Patients With Metastatic Colorectal Cancer Treated With Cetuximab Pablo Gajate, Javier Sastre, Inmaculada Bando, Clinical Colorectal Cancer Gastrointestinal OncologyMedicinePathologyColorectal CancerCancer Genomics	2012	36
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected Javier Sastre, Virginia de la Orden, Antonio Martínez, Clinical Colorectal Cancer Prognostic BiomarkersCancer EpidemiologyMedicineClinical CharacteristicsPathology	2020	30
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy Patricia Llovet, Javier Sastre, Julián Sanz‐Ortega, Molecular Diagnosis & Therapy Kras Codon 12MedicinePrognostic ValueColorectal CancerPathology	2015	26
Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition Lorena Martín-Morales, Paula Rofes, Eduardo Díaz‐Rubio, PLoS ONE Somatic VariantMultigene PanelMedicineGeneticsGenetic Epidemiology	2018	24
Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer Pilar Garré, Lorena Martín-Morales, Inmaculada Bando, Familial Cancer Lynch SyndromeSomatic VariantCancer PathologyCancer RiskMedicine	2013	15

Page 1